Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-02-14 11:11 am Sale | 13G | Aileron Therapeutics Inc. ALRN | ARMISTICE CAPITAL LLC | 1,460,620 4.99% | -676,469 (-31.65%) | View |
| 2020-02-03 3:24 pm Unchanged | 13G | Aileron Therapeutics Inc. ALRN | JENNISON ASSOCIATES LLC | 1,542,288 5.3% | 0 (Unchanged) | View |
| 2019-11-12 2:03 pm Sale | 13G | Aileron Therapeutics Inc. ALRN | PRUDENTIAL FINANCIAL INC PRU | 1,542,288 5.3% | -2,040,255 (-56.95%) | View |
| 2019-11-08 4:38 pm Sale | 13G | Aileron Therapeutics Inc. ALRN | JENNISON ASSOCIATES LLC | 1,542,288 5.25% | -2,040,255 (-56.95%) | View |
| 2019-08-13 5:00 pm Unchanged | 13D | Aileron Therapeutics Inc. ALRN | Lilly Ventures Fund I LLC | 1,094,987 3.9% | 0 (Unchanged) | View |